Significant Shareholder Files Intent to Sell $583K in RetinalGenix Technologies Stock
summarizeSummary
A significant shareholder, Steven Bayern for Bayern Capital LLC, has filed a Form 144 to sell 182,400 shares of RetinalGenix Technologies Inc. stock, valued at approximately $583,680.
check_boxKey Events
-
Intent to Sell Shares
Steven Bayern, representing Bayern Capital LLC, has filed a Form 144 indicating an intent to sell 182,400 shares of common stock.
-
Significant Value
The proposed sale has an approximate market value of $583,680.00.
-
Shareholder Disposition
The filer is identified as a shareholder, not an officer or director, and the shares were acquired via warrant exercise in 2018.
auto_awesomeAnalysis
Steven Bayern, representing Bayern Capital LLC, has filed a Form 144 indicating an intent to sell 182,400 shares of RetinalGenix Technologies Inc. stock. This proposed sale, valued at approximately $583,680, represents a notable disposition by a significant shareholder. While the filer is not an officer or director, such a filing can signal a desire for liquidity or a rebalancing of portfolio holdings. Investors should monitor for actual sales and any further disclosures regarding this position.
At the time of this filing, RTGN was trading at $3.20 on OTC in the Industrial Applications And Services sector, with a market capitalization of approximately $59.5M. The 52-week trading range was $0.25 to $20.00. This filing was assessed with negative market sentiment and an importance score of 7 out of 10.